Two medications. One goal.
Both work on the GLP-1 pathway — Tirzepatide adds a second mechanism for stronger results. Your clinician will help you determine which is the right fit based on your history, goals, and how your body responds.
Tirzepatide
The dual-action GLP-1 + GIP receptor agonist. The most effective weight-loss medication currently available, with clinical trials showing up to 20%+ body weight reduction.
agonist
Dual-pathway action
Tirzepatide activates both the GLP-1 and GIP receptors — two hormones that regulate blood sugar and appetite. By hitting both pathways simultaneously, it reduces hunger more effectively than single-agonist medications, slows gastric emptying so you feel full longer, and improves insulin sensitivity.
- Suppresses appetite via dual hormone receptors
- Slows digestion for extended satiety
- Improves insulin sensitivity and blood glucose
- Weekly subcutaneous injection protocol
Your program
We start with an initial consultation to assess candidacy, review your health history, and set your starting dose. Doses increase gradually over 4–20 weeks to your maintenance level. We pair your program with MIC+ and B12 shots to support metabolism and energy throughout your journey.
- Initial consultation + health intake
- Medication dispensed upon approval
- Weekly self-injection (we train you)
- Monthly check-ins with clinical staff
- MIC+ and B12 support shots included
Start with a consultation. Your clinician sets your starting dose and titrates up as needed. Most patients see meaningful results within 4–8 weeks.
Book ConsultationSemaglutide
The established GLP-1 receptor agonist with a proven track record. Clinical trials show 10–15% body weight reduction, with excellent tolerability and a strong safety profile.
agonist
GLP-1 pathway
Semaglutide mimics the GLP-1 hormone naturally released after eating. It signals the brain that you're full, reduces cravings, and slows food moving through your stomach. The result is consistent, sustainable caloric reduction without the willpower battle — you simply aren't as hungry.
- Reduces hunger signals in the brain
- Slows gastric emptying for longer fullness
- Improves blood glucose regulation
- Weekly subcutaneous injection protocol
Your program
Same structured approach as our Tirzepatide program — consultation first, then a gradual dose escalation to find your optimal maintenance level. Semaglutide is often the first-line recommendation for patients newer to GLP-1 therapy, with Tirzepatide available as an upgrade if needed.
- Initial consultation + health intake
- Medication dispensed upon approval
- Weekly self-injection (we train you)
- Monthly check-ins with clinical staff
- MIC+ and B12 support shots included
Start with a consultation. Your clinician confirms candidacy and sets your dose. A good starting point if you're new to GLP-1 therapy.
Book Consultation
